http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
NTRK Alterations in Pediatric High-Risk Malignancies Identified Through European Clinical Sequencing Programs Constitute Promising Drug Targets
Pfaff, E. (First author)DKFZ* ; Adam de Beaumais, T. ; Marchais, A. ; van Tilburg, C. M.DKFZ* ; Blattner-Johnson, M.DKFZ* ; Dirksen, U.DKFZ* ; Øra, I. ; Geoerger, B. ; Schleiermacher, G. ; Pfister, S.DKFZ* ; Witt, O.DKFZ* ; Jones, D. T. W.DKFZ* ; Vassal, G.
2021
American Society of Clinical Oncology
Alexandria, VA
This record in other databases: 
Please use a persistent id in citations: doi:10.1200/PO.20.00417
Note: #EA:B360#
Contributing Institute(s):
- Pediatric Glioma (B360)
- KKE Pädiatrische Onkologie (B310)
- DKTK HD zentral (HD01)
- DKTK ED ES zentral (ED01)
- B062 Pädiatrische Neuroonkologie (B062)
Research Program(s):
- 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)
Appears in the scientific report
2021
Database coverage:
; Clarivate Analytics Master Journal List ; Ebsco Academic Search ; Emerging Sources Citation Index ; SCOPUS ; Web of Science Core Collection